Clinical Pharmacokinetics of Vemurafenib in BRAF-Mutated Melanoma Patients

C M Nijenhuis, A D R Huitema, C Blank, J B A G Haanen, J V van Thienen, H Rosing, J H M Schellens, J H Beijnen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)125-128
Number of pages4
JournalJournal of Clinical Pharmacology
Volume57
Issue number1
DOIs
Publication statusPublished - Jan 2017

Keywords

  • vemurafenib
  • pharmacokinetics
  • therapeutic drug monitoring
  • routine clinical care
  • exposure-response
  • LC-MS/MS

Cite this